Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Tigulixostat Tablet vs Capsule in Healthy Subjects
NCT04886050Phase 1Completed
- Sponsor
- LG Chem
- Start
- Jul 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tigulixostat in gout and hyperuricemia (2 arms), sponsored by LG Chem. Primary endpoint: Area under the plasma concentration-time curve from zero to infinity at Day 8. Started Jul 2021; status: completed.
02
Drugs
tigulixostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT04886050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04886050.